Prognostic Value of Elevated High-Sensitivity Cardiac Troponin T Levels in Patients with Acute Ischemic Stroke Treated with Endovascular Thrombectomy

Yue-Zhou Cao,Lin-Bo Zhao,Sheng Liu,Qiang-Hui Liu,Lei Jiang,Chun-Gao Zhou,Zhen-Yu Jia,Wei-Zhong Zhou,Jin-Guo Xia,Wen-Tao Wu,Qing-Quan Zu,Shan-Shan Lu,Xiao-Quan Xu,Hai-Bin Shi
DOI: https://doi.org/10.1016/j.jocn.2019.03.030
IF: 2.116
2019-01-01
Journal of Clinical Neuroscience
Abstract:Our objective was to assess the impact of hs-cTnT elevation on functional outcome and mortality in AIS patients with large vessel occlusion (LVO) in the anterior circulation 3 months after ET and explore factors affecting hs-cTnT elevation. A total of 143 consecutive AIS patients with large vessel occlusion (LVO) in the anterior circulation following ET in a single stroke center were enrolled between January 2015 and November 2017. Hs-cTnT was quantitated on admission. Demographic characteristics, clinical data, functional outcome and allcause mortality were compared between patients with elevated hs-cTnT levels (>14 ng/L) and those with normal hs-cTnT levels (<= 14 ng/L). 58/143(40.6%) patients showed elevated hs-cTnT levels before El'. Factors independently associated with hs-cTnT elevation were admission NIHSS score (OR = 1.08, 95% Cl 1.01-1.16, p = 0.032), coronary heart disease (OR = 4.89, 95% Cl 1.82-13.11, p = 0.002) and congestive heart failure (OR = 4.10, 95% CI 1.07-15.68, p = 0.039). In the univariate analysis, patients with elevated hs-cTnT levels were at significantly higher risk of 3-month poor outcome (p = 0.029) and mortality (p < 0.001) than those with normal hs-cTnT levels. After multivariable analysis, hs-cTnT elevation 'remained an independent predictor of 3-month mortality (OR = 4.49, 95% CI 1.68-11.98, p = 0.003). In this cohort of AIS patients with LVO in the anterior circulation undergoing ET, hs-cTnT elevation is an independent predictor of 3-month mortality. Admission NIHSS score, coronary heart disease and congestive heart failure are independently associated with elevated hs-cTnT levels. (C) 2019 Elsevier Ltd. All rights reserved.
What problem does this paper attempt to address?